Hanger Helmet Study

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to examine a group of patients requiring helmet therapy (either patients with plagiocephaly or post-surgical patients) to compare outcomes of infants treated with the Hanger helmet (Hanger, Inc.) to outcomes of infants treated with the P Pod Helmet (Lorica Scientific, LLC). Currently both helmets are prescribed at CCHMC. The investigators' goal is to determine which helmet is more effective in skull remodeling and to standardize the investigators' care for these patient types.

Clinical Trial Description

The use of helmet therapy to correct abnormal head shape due to either positional plagiocephaly secondary to pressure on the posterior skull with infant position and furniture use or after minimally invasive surgery for craniosynostosis is currently the treatment of choice at Cincinnati Children's Hospital (CCHMC). Helmet treatment in children with positional plagiocephaly is initiated for infants between 4 and 9 months of age (at CCHMC). Helmet treatment for children undergoing surgery for craniosynostosis is initiated following endoscopic cranial vault and stip craniectomy surgery after swelling from the surgery has subsided (generally within two weeks of surgery). Treatment with helmet therapy has been shown to improve head shape in both patient diagnoses. There are two types of helmets available to the investigators' patients (Hanger Helmet and P Pod Helmet) and to date, no research has evaluated whether one helmet type is more efficient in reshaping the skull than the other type. The current study seeks to fill this gap in the literature by comparing the outcomes for infants treated with a Hanger Helmet to the outcomes for infants treated with a P Pod Helmet. The investigators will measure skull symmetry with a 3dMD camera and take routine cross lateral measurements with a caliper designed for this use. Infants participating in the study will be randomized using a computerized program, Minim. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02561728
Study type	Interventional
Source	Children's Hospital Medical Center, Cincinnati
Contact
Status	Withdrawn
Phase	N/A
Start date	July 2016
Completion date	October 2023

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00769847` - Endoscopic Treatment for Isolated, Single Suture Craniosynostosis	N/A
Completed	`NCT00077831` - Child and Infant Learning Project	N/A
Recruiting	`NCT03231085` - Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child	N/A
Active, not recruiting	`NCT02229968` - Efficacy of Amicar for Children Having Craniofacial Surgery	Phase 2
Completed	`NCT02287805` - Qualitative and Quantitative Study Which Aims to Determine the Specifics of the Announcement for the Diagnosis of Patients With Craniosynostosis and Their Parents to Better Support Them in Their Care	N/A
Enrolling by invitation	`NCT05911139` - Influence of General Anesthesia on the Dynamic Changes in Brain Damage Markers During and After Craniosynostosis Operations in Infancy
Completed	`NCT00912119` - Amicar Pharmacokinetics of Children Having Craniofacial Surgery	Phase 1
Completed	`NCT00106977` - Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)
Terminated	`NCT00722436` - Tranexamic Acid for Craniofacial Surgery	Phase 4
Completed	`NCT00367796` - Genetic Analysis of Craniosynostosis, Philadelphia Type	N/A
Completed	`NCT01898650` - MRI for Non-invasive Evaluation of Brain Stress	N/A
Active, not recruiting	`NCT03025763` - Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones
Completed	`NCT02188576` - The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery	Phase 4
Completed	`NCT00773643` - Osteogenic Profiling of Tissue From Children With Craniosynostosis	N/A
Enrolling by invitation	`NCT04704284` - Comparing MRI to CT on Pediatric Craniosynostosis.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.